Farbman, Eric S. et al "Efficacy results of a 12-month, dose-level blinded study of CVT-301 (levodopa inhalation powder) in patients with Parkinson’s disease (P2.8-048)." Neurology 92.15 Supplement (2019): P2.8-048. Web. 24 Aug. 2019.